MDM2 and glioblastoma: A 2-phenylindolylglyoxylyl dipeptide was designed to bind TSPO, leading to the disruption of MDM2-p53 interaction, cell-cycle arrest, and apoptosis in human GBM cells (Daniele et al., 2016).